Optogenetics Market By Light Equipment (Laser, Light Emitting Diode (LED) and Others), By Sensors (pH Sensors, Genetically Modified Calcium Indicators, Neurotransmitter Release, and Voltage-sensitive Fluorescent Proteins), By Actuators (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By Application (Retinal Disease Treatment, Cardiovascular Ailments, Neuroscience, Behavioral Tracking, and Pacing), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI60019 | Publish Date: March 2024 | No. of Pages: 180

Global Optogenetics Market By Market Companies

  • Coherent, Inc.
  • Thorlabs, Inc.
  • Cobalt, Inc.
  • Scientifica Ltd.
  • Laserglow Technologies
  • Regenxbio, Inc.
  • Assurex Health, Inc.
  • Addgene Inc.
  • UPenn Vector Core
  • Jackson Laboratories.

Recent News:

  • In February 2023, GenSight Biologics announced 1-year safety and efficacy data from the PIONEER Phase I/II clinical trial of GS030, an optical treatment candidate for retinitis pigmentosa.
  •  In June 2022, Bruker Corporation launched the NeuraLight 3D Ultra module to support advanced optical and neuroscience research applications on Bruker's Ultima multiphoton microscope.
  •  In September 2021, NeuroLux Inc. announced an exclusive partnership with TSE Systems to integrate its wireless technology with TSE Systems' IntelliCage and PhenoMaster platforms, providing optical, pharmacological, telemetry, and other capabilities for advanced behavioral neuroscience research.
  •  In June 2021, Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies to treat retinal diseases, announced that visual improvement for all evaluable patients with advanced retinitis pigmentosa (RP) persisted for one year following a single intravitreal injection in a Phase 1/2a clinical study of multispecific opsin (MCO) on retinal cells. Such studies advance the benefits of optogenetics.